Erzofri is an atypical antipsychotic that is administered once a month as an intramuscular injection by a health care professional.

“Medication adherence and discontinuation present a major challenge in the treatment of schizophrenia and schizoaffective disorder,” said Rongbing Yang, President of Luye Pharma Group.

Clinical psychologist, Dr. Corey Gonzales talks about the prevalence and content of auditory and visual hallucinations within ...

A woman involved in a wild brawl inside a 7-Eleven store has broken her silence for the first time as a coroner probes an ...

Luye Pharma Group today announced that ERZOFRI® extended-release injectable suspension is now available for commercial sale ...

TAIPEI (Taiwan News) — The Supreme Court has upheld the conviction of a mentally ill woman who fatally stabbed her mother and ...

Luye Pharma launches Erzofri ER injectable suspension to treat schizophrenia and schizoaffective disorder in US market: Princeton, New Jersey Tuesday, April 8, 2025, 15:00 Hrs [IS ...

A newer and innovative form of relational therapy is AVATAR Therapy. This approach works by “embodying” the voice through a ...

Meanings are not determined by situations, but we determine ourselves by the meanings we give to situations rdquo; ---Alfred ...